Skip to main content
. 2021 May 13;11:10220. doi: 10.1038/s41598-021-89621-6

Table 2.

Final list of screened SARS-CoV-2 specific neutralizing and therapeutic antibodies.

Neutralizing antibody Therapeutic antibody Sequence identity (%)
Name Length (aa) Name Length (aa)
C002 231 Tremelimumab 232 90
COV2-2015 230 Afasevikumab 231 92
COVA2-29 232 Tremelimumab 232 90
HbnC3t1p1_G4 224 Ipilimumab 226 90